CVE-2026-46458
ICU Scandinavia Boomerang is vulnerable to an information disclosure flaw where sensitive credential files are exposed via static HTTP. This allows an unauthenticated remote attacker…
Description
ICU Scandinavia Boomerang is vulnerable to an information disclosure flaw where sensitive credential files are exposed via static HTTP. This allows an unauthenticated remote attacker to retrieve plaintext service account and SMTP credentials by requesting specific XML files from the webroot. This issue has been fixed in version 2.4.18.029
Detection & mitigation playbook
VulnerabilityDetect
Scan your dependency tree (package-lock.json, pnpm-lock.yaml, requirements.txt, go.sum, etc.) for the affected component. O3's reachability analysis confirms whether the vulnerable code path is actually invoked in your application, so you act on real exposure instead of every transitive match.
Remediation status
No patched version of the affected component has shipped for CVE-2026-46458 yet. Where your build allows, override or pin the dependency away from the vulnerable range, and apply any maintainer-recommended mitigation.
Mitigate without a patch
If you can't upgrade right away: gate or disable the affected feature, validate untrusted input at the boundary, and avoid passing attacker-controlled data into the vulnerable path. O3's runtime protection blocks exploitation in production as an interim safeguard until the upgrade lands.
How O3 protects you
O3 pinpoints whether CVE-2026-46458 is reachable in your code and exactly where to fix it, then blocks exploitation in production at runtime until the patched version is deployed.
Tailored to CVE-2026-46458. Runtime protection reduces exposure until a permanent patch is applied and verified — it complements patching, it doesn't replace it.
Frequently Asked Questions
Is CVE-2026-46458 in your dependencies?
O3 detects CVE-2026-46458 across dependencies and uses function-level reachability to confirm whether the vulnerable code path is actually reachable — not just present. No false positives.